Radioimmunoassay of a 26,000-Dalton Plasma Insulin-Like Growth Factor-Binding Protein: Control by Nutritional Variables*
- 1 December 1988
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 67 (6) , 1225-1230
- https://doi.org/10.1210/jcem-67-6-1225
Abstract
Insulin-like growth factor I (IGF-I) is a peptide growth factor that circulates bound to carrier proteins. One form of carrier protein (mol wt. .apprx. 26K) is not believed to be GH dependent, is relatively unsaturated, and modulates the cellular response to IGF-I. This study was undertaken to determine the variables that control the plasma concentration of this protein, which was measured using the specific RIA. The mean plasma 26K IGF-binding protein (IGF-BP) concentration in 15 normal fasting subjects at 0800 h was 9.4 .+-. 4.4 (.+-. SD) .mu.g/L. The mean value in GH-deficient patients was increased to 19.5 .+-. 10.1 .mu.g/L (n = 60; P < 0.05), and it was 7.3 .+-. 4.3 .mu.g/L in patients with acromegaly (n = 31). The GH dependency of these changes is further supported by the observation that subjects who received GH injections had a 51% reduction in their fasting values. Nutritional intake appeared to be a more important controlling variable than GH. During an overnight fast plasma 26K IGF-BP values increased approximately 4-fold in 6 normal subjects. After 2 days of fasting, the mean value in 7 obese subjects rose progressively from 6.5 .+-. 2.3 to 11.7 .+-. 5.4 .mu.g/L (P < 0.001), and it increased further to 19.2 .+-. 5.9 .mu.g/L by day 4 of fasting; after 2 days of refeeding it returned to the prefasting level of 6.8 .+-. 1.9 .mu.g/L. Likewise, ingestion of a standard test meal resulted in a significant decrease in mean plasma 26K IGF-BP from a fasting value of 8.4 .+-. 2.9 to 5.6 .+-. 2.8 .mu.g/L 4 h postprandially (P < 0.05). In summary, the plasma concentrations of the 26K IGF-I-BP fluctuate widely in response to dietary manipulation, whereas GH status apears to be a secondary controlling variable.This publication has 15 references indexed in Scilit:
- Insulin-like growth factor-binding protein from human plasma. Purification and characterization.Journal of Biological Chemistry, 1986
- Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluidActa Endocrinologica, 1984
- Immunoassay of a Somatomedin-Binding Protein from Human Amniotic Fluid: Levels in Fetal, Neonatal, and Adult Sera*Journal of Clinical Endocrinology & Metabolism, 1984
- Isolation of a Somatomedin-Binding Protein from Preterm Amniotic Fluid. Development of a Radioimmunoassay*Journal of Clinical Endocrinology & Metabolism, 1984
- Isolation and characterization of a somatomedin‐binding protein from mid‐term human amniotic fluidEuropean Journal of Biochemistry, 1984
- Radioimmunoassay of placental protein 12: Levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women, and patients with trophoblastic diseaseAmerican Journal of Obstetrics and Gynecology, 1982
- Reduction of Plasma Immunoreactive Somatomedin C during Fasting in Humans*Journal of Clinical Endocrinology & Metabolism, 1981
- Induction of Immunoreactive Somatomedin C in Human Serum by Growth Hormone: Dose-Response Relationships and Effect on Chromatographic Profiles*Journal of Clinical Endocrinology & Metabolism, 1980
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Inhibition of the Action of Nonsuppressible Insulin-Like Activity on Isolated Rat Fat Cells by Binding to its Carrier ProteinJournal of Clinical Investigation, 1979